UnitedHealthvsVanda Pharmaceuticals

UNH and VNDA stock compared: price, dividend, valuation and results, from SEC filings.

UNH

UnitedHealth Group Incorporated

$339.85

Value $308B

+2.84%
UNH's page

VNDA

Vanda Pharmaceuticals Inc.

$3.44

Value $204M

-5.99%
VNDA's page

UnitedHealth (UNH) has a market value of $308B and Vanda Pharmaceuticals (VNDA) $204M. Over the last year, with dividends, UNH moved +12.9% and VNDA -32.9%. Dividend yield: UNH 2.67%, VNDA none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    UNH$308B

    VNDA$204M

    UNH is 1,515 times VNDA

  • Revenue, 12 months

    UNH$450B

    VNDA$229M

    UNH is 1,961 times VNDA

  • Net income, 12 months

    UNH$15.9B

    VNDA-$275M

  • Operating margin

    UNH5.3%

    VNDA-77.6%

    82.9 points apart

  • ROIC

    UNH11.3%

    VNDA-47.0%

    58.3 points apart

  • P/E

    UNH19.4

    VNDA–

  • Dividend yield

    UNH2.7%

    VNDA0.0%

    2.7 points apart

  • 5-year return

    UNH-15.4%

    VNDA-79.7%

    64.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

UNH-15.4%

VNDA-79.7%

5010015020222023202420252026
Returns by period
PeriodUNHWith dividendsVNDAWith dividends
1 year since November 19, 2025+12.9%Price +10.0%-32.9%Price -32.9%
3 years since November 20, 2023-32.4%-12.2% a yearPrice -36.5%-3.6%-1.2% a yearPrice -3.6%
5 years since November 19, 2021-15.4%-3.3% a yearPrice -22.8%-79.7%-27.3% a yearPrice -79.7%
10 years since November 21, 2016+166.8%+10.3% a yearPrice +125.9%-79.9%-14.8% a yearPrice -79.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

UNHUnitedHealthVNDAVanda Pharmaceuticals

Valuation

UNHVNDA
Valuation
Price$339.85$3.44
Market value$308B$204M
Enterprise value (EV)$354B$70M
P/E19.4–
P/E, 5-year median25.0–
P/B3.01.0
EV/EBIT14.8–
Free cash flow yield7.4%–

Results and growth

UNHVNDA
Results and growth
Revenue, 12 months$450B$229M
Net income, 12 months$15.9B-$275M
Free cash flow, 12 months$22.8B-$140M
Earnings per share, 12 months$17.52-$4.62
Revenue growth, year on year11.8%8.7%
Revenue growth a year, past+11.7%over 5 years-2.7%over 5 years
EPS growth a year, past-3.8%over 5 years–

Margins and returns on capital

UNHVNDA
Margins and returns on capital
Gross margin88.3%93.6%
Operating margin5.3%-77.6%
Net margin3.5%-119.9%
ROIC11.3%-47.0%
ROE15.5%-92.0%

Balance sheet

UNHVNDA
Balance sheet
Cash$28.5B$140M
Total debt$74.3B$22M
Net debt / EBITDA1.6–
Interest cover6.2×–

Dividends and buybacks

UNHVNDA
Dividends and buybacks
Dividend yield2.7%–
Dividend per share, 12 months$9.06–
Dividend growth a year, past+12.6%over 5 years–
Buyback yield1.8%–
Shareholder yield4.5%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: UNH or VNDA

Didn't find what you were looking for?

Ask us
Which is bigger, UnitedHealth or Vanda Pharmaceuticals?

By market value, UnitedHealth ($308B) is about 1,514.9 times Vanda Pharmaceuticals ($204M), at today's prices.

How did UNH and VNDA stock do over the last 10 years?

Since November 21, 2016, UNH's price moved +125.9% and VNDA's -79.9%. With dividends: UNH +166.8% (+10.3% a year), VNDA -79.9% (-14.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, UNH or VNDA?

The dividend yield at today's price is 2.67% for UnitedHealth and none for Vanda Pharmaceuticals. Over the last twelve months they paid $9.06 and – per share.

Which has the higher profit margins, UnitedHealth or Vanda Pharmaceuticals?

Over the last twelve months, the net margin was 3.5% for UnitedHealth and -119.9% for Vanda Pharmaceuticals, and the operating margin 5.3% and -77.6%. Revenue was $450B and $229M.

Which is the better investment, UnitedHealth or Vanda Pharmaceuticals?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.